{
  "slug": "relevium-medical",
  "name": "Relevium Medical",
  "yc_id": 27168,
  "batch": "Summer 2022",
  "website": "https://relevium-medical.com/",
  "web_data": {
    "web_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T01:19:10.607983",
    "website": "https://relevium-medical.com/",
    "website_status": {
      "reachable": true,
      "status_code": 200,
      "response_time_ms": 3998.51,
      "final_url": "https://relevium-medical.com/",
      "redirected": false,
      "checked_at": "2025-10-17T01:19:14.606513"
    },
    "ssl_security": {
      "disabled": true,
      "reason": "certificate_verification_failed"
    },
    "domain_info": {
      "domain": "relevium-medical.com",
      "registrar": "Blacknight Internet Solutions Ltd.",
      "creation_date": "2020-07-04T20:59:11",
      "expiration_date": "2026-07-04T20:59:11",
      "domain_age_days": 1930,
      "domain_age_years": 5.3,
      "name_servers": [
        "NS53.DOMAINCONTROL.COM",
        "NS54.DOMAINCONTROL.COM"
      ]
    },
    "social_links": {
      "twitter": "https://twitter.com/ReleviumMed",
      "linkedin": "https://www.linkedin.com/company/releviummedical/",
      "github": null,
      "facebook": null,
      "instagram": null,
      "youtube": null
    },
    "security_headers": {
      "strict_transport_security": true,
      "content_security_policy": false,
      "x_frame_options": true,
      "x_content_type_options": true,
      "x_xss_protection": false,
      "referrer_policy": false,
      "security_score": 50,
      "server": "Squarespace"
    }
  },
  "enrichment_version": "1.0.0",
  "enriched_at": "2025-10-17T10:39:14.714344",
  "phase1_complete": true,
  "phase2_complete": false,
  "phase3_complete": false,
  "phase4_complete": false,
  "phase5_complete": false,
  "ai_insights": {
    "ai_insights_version": "1.0.0",
    "model_used": "google/gemini-2.0-flash-001",
    "enriched_at": "2025-10-17T12:42:12.834838",
    "status": "success",
    "market_analysis": {
      "market_size": "very large",
      "market_stage": "mature",
      "key_trends": [
        "Aging population increasing osteoarthritis prevalence",
        "Growing demand for non-opioid pain management solutions",
        "Advancements in injectable drug delivery systems"
      ]
    },
    "competitive_positioning": {
      "competitive_moat": "Patent protection on injectable gel formulation and delivery method.",
      "differentiation": "Non-opioid, long-lasting pain relief with a single injection.",
      "competitive_advantages": [
        "Reduced reliance on addictive opioids",
        "Potential for improved patient compliance due to less frequent injections"
      ],
      "competitive_vulnerabilities": [
        "Regulatory hurdles and clinical trial success",
        "Competition from established pharmaceutical companies with existing osteoarthritis treatments"
      ]
    },
    "business_model": {
      "revenue_model": "Pharmaceutical sales (direct or through partnerships)",
      "scalability": "high",
      "capital_intensity": "high"
    },
    "growth_assessment": {
      "growth_stage": "seed",
      "growth_indicators": [
        "Successful completion of preclinical and clinical trials",
        "Securing regulatory approvals (FDA)",
        "Partnerships with pharmaceutical companies or distributors"
      ],
      "growth_bottlenecks": [
        "Clinical trial failures",
        "Manufacturing scalability",
        "Securing sufficient funding for clinical development"
      ]
    },
    "risk_analysis": {
      "market_risk": "medium",
      "technology_risk": "high",
      "execution_risk": "medium",
      "overall_risk_score": 7,
      "key_risks": [
        "Clinical trial failure",
        "Regulatory approval delays",
        "Competition from existing and emerging therapies"
      ]
    },
    "investment_thesis": {
      "strengths": [
        "Large and growing market for osteoarthritis treatment",
        "Potential for a disruptive, non-opioid pain management solution",
        "Experienced team with relevant scientific and medical expertise"
      ],
      "concerns": [
        "High capital requirements for clinical development",
        "Regulatory and reimbursement uncertainties"
      ],
      "exit_potential": "acquisition",
      "comparable_companies": [
        "Flexion Therapeutics",
        "Anika Therapeutics"
      ]
    },
    "recommendations": {
      "next_steps": [
        "Secure Series A funding to advance clinical trials",
        "Strengthen intellectual property protection",
        "Develop a clear regulatory strategy"
      ],
      "expansion_opportunities": [
        "Explore applications of the injectable gel technology for other musculoskeletal conditions",
        "Develop strategic partnerships with pharmaceutical companies for commercialization"
      ]
    },
    "tokens_used": {
      "prompt": 711,
      "completion": 653,
      "total": 1364,
      "estimated_cost": 0.000249
    }
  },
  "phase8_complete": true
}